Cite
Safety of ninety-minute daratumumab infusion.
MLA
Lombardi, Jeffrey, et al. “Safety of Ninety-Minute Daratumumab Infusion.” Journal of Oncology Pharmacy Practice, vol. 27, no. 5, July 2021, pp. 1080–85. EBSCOhost, https://doi.org/10.1177/1078155220951231.
APA
Lombardi, J., Boulin, M., Devaux, M., Cransac, A., Pistre, P., Pernot, C., Payssot, A., Lafon, I., Caillot, D., & Gueneau, P. (2021). Safety of ninety-minute daratumumab infusion. Journal of Oncology Pharmacy Practice, 27(5), 1080–1085. https://doi.org/10.1177/1078155220951231
Chicago
Lombardi, Jeffrey, Mathieu Boulin, Madeline Devaux, Amélie Cransac, Pauline Pistre, Corinne Pernot, Alexandre Payssot, Ingrid Lafon, Denis Caillot, and Pauline Gueneau. 2021. “Safety of Ninety-Minute Daratumumab Infusion.” Journal of Oncology Pharmacy Practice 27 (5): 1080–85. doi:10.1177/1078155220951231.